Abiopharma

(99% Neutral) TRANSCODE THERAPEUTICS, INC. (RNAZ) Provides Update on Survival for Orthotopic Glioblastoma Models

Prenetics Global Ltd (PRE) Files Form 6-K

Johnson & Johnson unveils new data showing nipocalimab is the first and only investigational FcRn blocker with potential to reduce systemic lupus erythematosus (SLE) activity in a Phase 2 study

Elanco Animal Health Inc. - Elanco to Participate in the 44th Annual J.P. Morgan Healthcare Conference

(90% Positive) Denali Therapeutics Inc. (DNLI) Announces Enrollment Update for year Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

Edgewise Therapeutics - Edgewise Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026

SAB BIO to Present at the 44th Annual J.P. Morgan Healthcare Conference

(99% Neutral) DARE BIOSCIENCE, INC. (DARE) Files Form 8-K

Stereotaxis Receives FDA Approval for MAGiC Ablation Catheter

TransCode Therapeutics Announces Publication of Preclinical Data Supporting Therapeutic Potential of TTX-MC138 in Glioblastoma

(90% Positive) Compass Therapeutics, Inc. (CMPX) Announces Enrollment Update for observed Due to Patient Enrollment Issues, Regulatory Process, Safety Review

Nortech Systems Names Andrew Walko Senior Vice President of Global Operations

(99% Neutral) NORTECH SYSTEMS INCORPORATED (NSYS) Files Form 8-K

(99% Neutral) EARTH SCIENCE TECH, INC. (ETST) Files Form 8-K

Thermo Fisher Scientific - Thermo Fisher Scientific to Present at the J.P. Morgan 2026 Healthcare Conference